Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Restoration of the somatotropic axis with preserved pulsatility (P 800 cumulative) Tesamorelin Chemical Identity Stabilized synthetic analogue of human GHRH (44 amino acids) Tesamorelin Clinical Tolerability Safety profile evaluated in Phase III clinical trials in humans Published Clinical Data Phase III randomized controlled clinical trials published in NEJM and JAMA 15.2% Reduction of visceral adipose tissue at 26 weeks (2 mg SC/day vs placebo) Results at 26 Weeks 18% Reduction of visceral and hepatic fat at 12 months 12-Month Results Important Notice Search Only Not intended for human consumption
Preclinical research suggests that Ipamorelin may: Support bone density and skeletal strength Aid muscle repair and growth Promote healthy gastric function and motility Stimulate insulin release for metabolic support These attributes make Ipamorelin a leading candidate in growth hormone, tissue regeneration, and performance-related research
The detailed comparison is in our complete Tesamorelin guide explaining what it is, how it works, and why visceral fat searches are skyrocketing
To make this even clearer, heres a simple comparison table for common scenarios with a 5mg vial of Ipamorelin: As you can see, the more diluent you add, the less concentrated the solution becomes, meaning you'll need to draw a larger volume for the same dose
For face procedures, where the inflammatory field is small and the priority is incision quality and skin remodeling, GHK-Cu does most of the work, so I run GLOW
Chapter 3: The Masterpiece in Practice How to Use It for Maximum Radiance To experience the full artistry of this formulation, correct application is key
